Recorded fact · drug.label_indication
drug.label_indication for dapagliflozin|heart-failure
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 1c13a9c7 resolves to.
The record
| Fact id | 1c13a9c75b1aaf6decec3b88 |
|---|---|
| Entity | drug: dapagliflozin|heart-failure |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260710 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
To reduce the risk of CV death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 1293224e485bd0390adcc09fc101015a0294b7a7d34c99c0df158c6b4e37a0dd.
The value
{
"ingredient": "DAPAGLIFLOZIN",
"conditionId": "heart-failure",
"conditionName": "Heart failure",
"matchedAlias": "heart failure",
"context": "risk-reduction",
"brand": "FARXIGA",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "01f90c94-71cb-4a1f-81ff-8004b850529b",
"labelEffectiveTime": "20260710",
"labelsRead": 21,
"labelsNaming": 6,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 446abbad95e87785767364e11b019a473fc5b637042b22acb79fa07b66a32c1d.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.